Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.60
-0.03 (-0.28%)
At close: Feb 23, 2026, 4:00 PM EST
10.62
+0.02 (0.19%)
After-hours: Feb 23, 2026, 7:00 PM EST

Medifast Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
75.189.41105.56115.73119140.16168.56174.74191.02235.87296.19348.98337.25390.4453.33417.6377.83413.4394.19340.67
Revenue Growth (YoY)
-36.90%-36.21%-37.38%-33.77%-37.70%-40.58%-43.09%-49.93%-43.36%-39.58%-34.66%-16.43%-10.74%-5.56%15.00%22.58%42.63%52.28%79.18%90.89%
Cost of Revenue
22.9627.2528.9131.4830.7834.4945.1247.4549.6558.4985.47102.5991.45107.55131.65115.3199.55106.34100.4892.12
Gross Profit
52.1462.1676.6484.2588.22105.67123.44127.29141.37177.38210.72246.39245.79282.85321.68302.29278.29307.06293.71248.55
Selling, General & Admin
58.9465.1476.6184.5173.71102.47130.21118.35131.49150.57170.91191.88199.8233.59271.52246.3230.35250.69231.17194.75
Research & Development
11.11.111.31.11.111.21.31.111.21.11.20.91.11.21.11
Operating Expenses
59.9466.2477.7185.5175.01103.57131.31119.35132.69151.87172.01192.88201234.69272.72247.2231.45251.89232.27195.75
Operating Income
-7.8-4.08-1.07-1.2613.212.11-7.887.948.6825.5138.7153.5144.7948.1648.9655.0946.8455.1761.4352.8
Interest Expense
------------0.18-0.18-0.26-0.16-0.1-0.09-0.09-0.07-
Interest & Investment Income
1.421.431.371.30.951.331.31.221.181.030.46--------0.02
Other Non Operating Income (Expenses)
0-02.570.49-0.39-1.86-4.072.42-0.050.01-0.05-0-0.01-0.02-0-0.020.010.12-0.020.02
EBT Excluding Unusual Items
-6.38-2.662.880.5313.781.58-10.6511.599.826.5539.1253.3344.647.8848.854.9846.7555.1961.3552.84
Merger & Restructuring Charges
-----12.5--------12.2-------
Pretax Income
-6.38-2.662.880.531.281.58-10.6511.599.826.5539.1253.3332.4147.8848.854.9846.7555.1961.3552.84
Income Tax Expense
11.74-0.40.41.30.470.45-2.53.273.773.428.8413.365.8911.729.6813.212.7313.2114.3811.78
Earnings From Continuing Operations
-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.0241.9846.9641.06
Net Income
-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.0241.9846.9641.06
Net Income to Common
-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.0241.9846.9641.06
Net Income Growth
-----86.73%-95.12%--79.19%-77.24%-36.02%-22.58%-4.34%-22.06%-13.88%-16.71%1.75%21.54%21.85%114.10%122.24%
Shares Outstanding (Basic)
1111111111111111111111111111111212121212
Shares Outstanding (Diluted)
1111111111111111111111111111111212121212
Shares Change (YoY)
0.07%0.18%1.13%-0.09%0.44%0.35%0.18%0.54%-0.53%-0.99%-4.53%-6.35%-6.04%-6.30%-3.57%-2.04%-1.45%-0.61%0.31%0.48%
EPS (Basic)
-1.65-0.210.23-0.070.070.10-0.750.760.552.122.783.682.433.303.443.622.933.594.003.49
EPS (Diluted)
-1.65-0.210.22-0.070.070.10-0.750.760.552.122.773.672.413.273.423.592.913.563.963.46
EPS Growth
-----87.20%-95.28%--79.29%-77.29%-35.17%-19.01%2.23%-17.42%-8.15%-13.64%3.76%23.37%22.34%112.90%121.80%
Free Cash Flow
-6.6310.75-4.761.88-7.237.6811.135.449.5828.2541.461.9442.6853.6340.9240.66-19.085.4113.2860.73
Free Cash Flow Per Share
-0.600.98-0.430.17-0.660.701.020.500.882.583.795.683.884.863.583.49-1.630.461.125.11
Dividend Per Share
---------1.6501.6501.6501.6401.6401.6401.6401.4201.4201.4201.420
Dividend Growth
---------0.61%0.61%0.61%15.49%15.49%15.49%15.49%25.66%25.66%25.66%25.66%
Gross Margin
69.43%69.52%72.61%72.80%74.13%75.39%73.23%72.85%74.01%75.20%71.14%70.60%72.88%72.45%70.96%72.39%73.65%74.28%74.51%72.96%
Operating Margin
-10.39%-4.56%-1.01%-1.09%11.10%1.50%-4.67%4.54%4.54%10.81%13.07%15.33%13.28%12.34%10.80%13.19%12.40%13.35%15.58%15.50%
Profit Margin
-24.13%-2.53%2.35%-0.67%0.67%0.80%-4.84%4.76%3.16%9.81%10.22%11.45%7.86%9.26%8.63%10.01%9.01%10.15%11.91%12.05%
Free Cash Flow Margin
-8.83%12.02%-4.51%1.63%-6.08%5.48%6.60%3.11%5.01%11.98%13.98%17.75%12.65%13.74%9.03%9.74%-5.05%1.31%3.37%17.83%
EBITDA
-4.34-0.632.982.0216.45.3-4.8111.212.0328.9242.0756.4947.7551.0151.757.5349.8856.4962.7653.92
EBITDA Margin
-5.78%-0.70%2.82%1.74%13.78%3.78%-2.85%6.41%6.30%12.26%14.21%16.19%14.16%13.06%11.40%13.78%13.20%13.66%15.92%15.83%
D&A For EBITDA
3.473.454.053.283.193.193.073.263.353.413.372.972.952.852.732.443.051.311.331.12
EBIT
-7.8-4.08-1.07-1.2613.212.11-7.887.948.6825.5138.7153.5144.7948.1648.9655.0946.8455.1761.4352.8
EBIT Margin
-10.39%-4.56%-1.01%-1.09%11.10%1.50%-4.67%4.54%4.54%10.81%13.07%15.33%13.28%12.34%10.80%13.19%12.40%13.35%15.58%15.50%
Effective Tax Rate
--13.74%246.77%37.18%28.45%-28.22%38.43%12.87%22.59%25.05%18.18%24.48%19.84%24.00%27.22%23.94%23.44%22.29%
Advertising Expenses
-0.71.64.6-4.62.82.5------------
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q